CLINICAL_TRIALS
trial_result
· 2013-06-07
Clinical Trial Update: Ranibizumab and Reduced Fluence PDT for AMD [Phase 2]
Summary
Phase 2 trial evaluating ranibizumab with reduced-fluence photodynamic therapy for age-related macular degeneration. The study is completed and results were pos…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Texas Retina Associates | Conditions: Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2013-06-07